. . .  drugs just aren't cutting it. The poor drug industry has been hard put to come up with a drug for hypertension that doesn't significantly reduce quality of life with side effects like dizziness, nausea, arrhythmias and sexual problems, and in addition contribute over time to chronic disease. The new angiotensin receptor blockers were recently linked in The Lancet Oncology with developing prostate, breast and lung cancers. It's also been hard for them to come up with drugs that do the job. In a 2008 Canadian Family Physician, Richard Nahas, MD, CCFP, says only about 1/3 of those taking hypertension meds achieve optimal blood pressure control. Therefore it's not surprising, although refreshing, to see some serious attention being paid in medical journals to non-drug therapies. Recently, in The Journal of Clinical Hypertension, two MDs discussed the value of the low-sodium DASH diet (see my article on the DASH diet for a description), exercise, weight reduction, moderate a…